BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30256431)

  • 1. A novel PSMA/GCPII-deficient mouse model shows enlarged seminal vesicles upon aging.
    Vorlová B; Sedlák F; Kašpárek P; Šrámková K; Malý M; Zámečník J; Šácha P; Konvalinka J
    Prostate; 2019 Feb; 79(2):126-139. PubMed ID: 30256431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
    Sedlák F; Kvasnička A; Marešová B; Brumarová R; Dobešová D; Dostálová K; Šrámková K; Pehr M; Šácha P; Friedecký D; Konvalinka J
    ACS Chem Neurosci; 2024 Apr; 15(7):1342-1355. PubMed ID: 38377674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
    Naushad SM; Shree Divyya P; Janaki Ramaiah M; Alex Stanley B; Prasanna Lakshmi S; Vishnupriya J; Kutala VK
    Cancer Genet; 2015 Nov; 208(11):552-8. PubMed ID: 26471812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.
    Evans JC; Malhotra M; Cryan JF; O'Driscoll CM
    Br J Pharmacol; 2016 Nov; 173(21):3041-3079. PubMed ID: 27526115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
    Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Subbarao SA; Kutala VK
    Gene; 2013 Mar; 516(1):76-81. PubMed ID: 23266799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.
    Vornov JJ; Peters D; Nedelcovych M; Hollinger K; Rais R; Slusher BS
    Neurochem Res; 2020 Jun; 45(6):1256-1267. PubMed ID: 31749072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glutamate carboxypeptidase II in human brain.
    Sácha P; Zámecník J; Barinka C; Hlouchová K; Vícha A; Mlcochová P; Hilgert I; Eckschlager T; Konvalinka J
    Neuroscience; 2007 Feb; 144(4):1361-72. PubMed ID: 17150306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound.
    Airan RD; Foss CA; Ellens NP; Wang Y; Mease RC; Farahani K; Pomper MG
    Mol Imaging Biol; 2017 Feb; 19(1):24-30. PubMed ID: 27481359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
    Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
    J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
    Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
    Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GCPII imaging and cancer.
    Foss CA; Mease RC; Cho SY; Kim HJ; Pomper MG
    Curr Med Chem; 2012; 19(9):1346-59. PubMed ID: 22304713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
    Bacich DJ; Pinto JT; Tong WP; Heston WD
    Mamm Genome; 2001 Feb; 12(2):117-23. PubMed ID: 11210180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMA expression in the Hi-Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool.
    Simons BW; Turtle NF; Ulmert DH; Abou DS; Thorek DLJ
    Prostate; 2019 May; 79(6):678-685. PubMed ID: 30656716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
    Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
    Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.
    Sommer U; Siciliano T; Ebersbach C; Beier AK; Stope MB; Jöhrens K; Baretton GB; Borkowetz A; Thomas C; Erb HHH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition.
    Zink CF; Barker PB; Sawa A; Weinberger DR; Wang M; Quillian H; Ulrich WS; Chen Q; Jaffe AE; Kleinman JE; Hyde TM; Prettyman GE; Giegerich M; Carta K; van Ginkel M; Bigos KL
    Am J Psychiatry; 2020 Dec; 177(12):1129-1139. PubMed ID: 33256444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide.
    Conway RE; Rojas C; Alt J; Nováková Z; Richardson SM; Rodrick TC; Fuentes JL; Richardson NH; Attalla J; Stewart S; Fahmy B; Barinka C; Ghosh M; Shapiro LH; Slusher BS
    Angiogenesis; 2016 Oct; 19(4):487-500. PubMed ID: 27387982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.